Our Journey Beyond Sunset Boulevard : : evidence-based analysis of tumor-targeted gene- & immuno-therapies shine a critical spotlight on "true" long-term cancer-free survival / / by Erlinda M. Gordon and Frederick L. Hall.
The revival of DeltaRex-G (formerly Rexin-G)-the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history-returned active tumor surveillance and a precision-guided "silver bullet" (dnG1 killer gene) to the cancer clinic with "Expanded Access" in 2019. Empow...
Saved in:
| VerfasserIn: | |
|---|---|
| TeilnehmendeR: | |
| Place / Publishing House: | London : : IntechOpen,, 2021. ©2021 |
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 online resource (xii, 56 pages) :; illustrations |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Other title: | Our Journey Beyond Sunset Boulevard |
|---|---|
| Summary: | The revival of DeltaRex-G (formerly Rexin-G)-the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history-returned active tumor surveillance and a precision-guided "silver bullet" (dnG1 killer gene) to the cancer clinic with "Expanded Access" in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of "informed consent," this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors-validating "pathotropic" (disease-seeking) tumor targeting avant la lettre. |
| Hierarchical level: | Monograph |
| Statement of Responsibility: | by Erlinda M. Gordon and Frederick L. Hall. |